• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use.

作者信息

van den Hoogen Lucas L, Fritsch-Stork Ruth D E, Versnel Marjan A, Derksen Ronald H Wm, van Roon Joël A G, Radstake Timothy R Dj

机构信息

Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.

出版信息

Ann Rheum Dis. 2016 Dec;75(12):e81. doi: 10.1136/annrheumdis-2016-210485. Epub 2016 Sep 28.

DOI:10.1136/annrheumdis-2016-210485
PMID:27689737
Abstract
摘要

相似文献

1
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use.抗磷脂综合征中单核细胞I型干扰素特征与促炎单核细胞亚群、羟氯喹和他汀类药物的使用有关。
Ann Rheum Dis. 2016 Dec;75(12):e81. doi: 10.1136/annrheumdis-2016-210485. Epub 2016 Sep 28.
2
Response to: 'Monocyte type I interferon signature in antiphospholipid syndrome is related to pro-inflammatory monocyte subsets, hydroxychloroquine and statin use' by van den Hoogen et al.对范登·霍根等人的《抗磷脂综合征中单核细胞I型干扰素特征与促炎单核细胞亚群、羟氯喹和他汀类药物使用的关系》的回应
Ann Rheum Dis. 2016 Dec;75(12):e82. doi: 10.1136/annrheumdis-2016-210529. Epub 2016 Oct 21.
3
Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications.抗磷脂综合征中 I 型干扰素基因表达：发病机制、临床及治疗意义。
J Autoimmun. 2019 Nov;104:102311. doi: 10.1016/j.jaut.2019.102311. Epub 2019 Aug 1.
4
Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.羟氯喹在系统性红斑狼疮及抗磷脂抗体阳性患者中预防血栓形成的应用。
Curr Rheumatol Rep. 2011 Feb;13(1):77-80. doi: 10.1007/s11926-010-0141-y.
5
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.系统性红斑狼疮患者心血管疾病的一级预防：病例系列与文献综述
Lupus. 2017 Dec;26(14):1463-1472. doi: 10.1177/0961203317722847. Epub 2017 Aug 8.
6
A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.前瞻性开放性氟伐他汀治疗抗磷脂抗体阳性患者促炎和促血栓形成生物标志物的初步研究。
Ann Rheum Dis. 2014 Jun;73(6):1176-80. doi: 10.1136/annrheumdis-2013-203622. Epub 2013 Aug 9.
7
Bioinformatic analysis and experimental verification reveal expansion of monocyte subsets with an interferon signature in systemic lupus erythematosus patients.生物信息学分析和实验验证表明，系统性红斑狼疮患者中具有干扰素特征的单核细胞亚群有所扩增。
Arthritis Res Ther. 2025 Apr 25;27(1):96. doi: 10.1186/s13075-025-03560-5.
8
Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation.抗磷脂综合征谱中 I 型干扰素通路的激活：与疾病亚组和系统性抗磷脂综合征表现的关联。
Front Immunol. 2024 Mar 14;15:1351446. doi: 10.3389/fimmu.2024.1351446. eCollection 2024.
9
Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations.原发性抗磷脂综合征中 I 型干扰素特征：临床与实验室关联。
Front Immunol. 2019 Mar 15;10:487. doi: 10.3389/fimmu.2019.00487. eCollection 2019.
10
Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.基因谱分析揭示了抗磷脂综合征、系统性红斑狼疮和狼疮合并抗磷脂综合征中动脉粥样硬化和心血管疾病发病机制中的特定分子途径。
Ann Rheum Dis. 2015 Jul;74(7):1441-9. doi: 10.1136/annrheumdis-2013-204600. Epub 2014 Mar 11.

引用本文的文献

1
Immunohistochemical analysis reveals higher Myxovirus resistance protein 1 expression and increased macrophage count in placentas from patients with systemic rheumatic diseases.免疫组织化学分析显示，系统性风湿疾病患者胎盘内的抗黏液病毒蛋白1表达较高，巨噬细胞数量增加。
Rheumatol Int. 2025 Apr 4;45(4):90. doi: 10.1007/s00296-025-05856-w.
2
Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications.他汀类药物作为血栓性抗磷脂综合征的辅助抗栓药物：作用机制及临床意义
Cells. 2025 Feb 28;14(5):353. doi: 10.3390/cells14050353.
3
Antiphospholipid Antibodies as Key Players in Systemic Lupus Erythematosus: The Relationship with Cytokines and Immune Dysregulation.
抗磷脂抗体在系统性红斑狼疮中的关键作用：与细胞因子和免疫失调的关系。
Int J Mol Sci. 2024 Oct 20;25(20):11281. doi: 10.3390/ijms252011281.
4
Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression.原发性抗磷脂综合征的肾脏全转录组谱分析显示补体、干扰素和 NETs 相关基因表达。
Rheumatology (Oxford). 2024 Nov 1;63(11):3184-3190. doi: 10.1093/rheumatology/keae397.
5
Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus.系统性红斑狼疮患者自身抗体与干扰素特征及中性粒细胞胞外诱捕网形成的关联
J Transl Autoimmun. 2024 Jun 20;9:100246. doi: 10.1016/j.jtauto.2024.100246. eCollection 2024 Dec.
6
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.自身免疫和肌肉骨骼疾病中 I 型干扰素通路激活与临床结局的相关性：一项系统文献回顾，为 EULAR 要点提供信息。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2022-002864.
7
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.I 型干扰素通路检测在风湿和肌肉骨骼疾病研究中的应用：系统文献综述为 EULAR 考虑要点提供信息。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2022-002876.
8
Clinical Management of Thrombotic Antiphospholipid Syndrome.血栓性抗磷脂综合征的临床管理
J Clin Med. 2022 Jan 29;11(3):735. doi: 10.3390/jcm11030735.
9
An Update on Antiphospholipid Syndrome.抗磷脂综合征的最新研究进展。
Curr Rheumatol Rep. 2022 Jan 5;23(12):84. doi: 10.1007/s11926-021-01051-5.
10
Dendritic Cells and Antiphospholipid Syndrome: An Updated Systematic Review.树突状细胞与抗磷脂综合征：最新系统评价
Life (Basel). 2021 Aug 9;11(8):801. doi: 10.3390/life11080801.